Repository logo
 

Delineating the topography of amyloid-associated cortical atrophy in Down syndrome.

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Authors

Padilla, Concepcion 
Annus, Tiina 
Wilson, Liam R 
Hong, Young T 

Abstract

Older adults with Down syndrome (DS) often have Alzheimer's disease (AD) neuropathologies. Although positron emission tomography imaging studies of amyloid deposition (beta amyloid, Aβ) have been associated with worse clinical prognosis and cognitive impairment, their relationships with cortical thickness remain unclear in people with DS. In a sample of 44 DS adults who underwent cognitive assessments, [11C]-PiB positron emission tomography, and T1-weighted magnetization-prepared rapid gradient echo, we used mixed effect models to evaluate the spatial relationships between Aβ binding with patterns of cortical thickness. Partial Spearman correlations were used to delineate the topography of local Aβ-associated cortical thinning. [11C]-PiB nondisplaceable binding potential was negatively associated with decreased cortical thickness. Locally, regional [11C]-PiB retention was negatively correlated with cortical thickness in widespread cortices, predominantly in temporoparietal regions. Contrary to the prevailing evidence in established AD, we propose that our findings implicate Aβ in spatial patterns of atrophy that recapitulated the "cortical signature" of neurodegeneration in AD, conferring support to recent recommendations for earlier disease-interventions.

Description

Keywords

Alzheimer's disease, Amyloid, Atrophy, Dementia, Down syndrome, MRI, PET, Adult, Aged, Amyloid beta-Peptides, Amyloidogenic Proteins, Atrophy, Cerebral Cortex, Diffusion Magnetic Resonance Imaging, Down Syndrome, Female, Humans, Male, Middle Aged, Positron-Emission Tomography

Journal Title

Neurobiol Aging

Conference Name

Journal ISSN

0197-4580
1558-1497

Volume Title

80

Publisher

Elsevier BV
Sponsorship
Medical Research Council (G1002252)
Medical Research Council (G0900903)
Alzheimer's Research UK Health Foundation CLARE